Remove Bioinformatics Remove RNA Remove Science
article thumbnail

NGS is evolving: collaboration and tech lead the way

Drug Target Review

Several strategic partnerships formed by Beckman Coulter Life Sciences illustrate how cooperative models and an open‐chemistry approach facilitating advances in genomics research. Pillar and Beckman Coulter Life Sciences tested a 22‐gene panel for solid tumour testing, comparing the automated NGS workflow with a manual process.

RNA 92
article thumbnail

Scientific workflow for hypothesis testing in drug discovery: Part 1

Drug Target Review

This includes verifying the experimental design and understanding how the data was generated whether it was from RNA sequencing, mass spectrometry, or other biological assays. About the authors Dr Raminderpal Singh Dr Raminderpal Singh is a recognised visionary in the implementation of AI across technology and science-focused industries.

RNA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What single cells are revealing about brain disorders

Drug Target Review

From maths and physics to molecular biology Schnall-Levin did not begin in the life sciences. “I I got my eyes opened to molecular biology, bioinformatics, computational biology and these emerging fields at the time.” I took a couple of other software startup opportunities,” he adds, “but I realised I missed the genomics and science.

article thumbnail

Therapeutic Oligos 2025 Keynote Speakers Announced

Elrig

This second ELRIG meeting on Therapeutic Oligonucleotides brings together esteemed scientists from academia, industry, and other members of the drug discovery community to explore the discovery, validation, and targeting of oligonucleotide-based drug candidates, including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA).

RNA 59
article thumbnail

Fixing failed drugs: AI solutions for toxicity in drug discovery – part 2

Drug Target Review

In Part 2 of our conversation with Layla Hosseini-Gerami, Chief Data Science Officer at Ignota Labs , we explore the many forms of toxicity and how AI-powered tools like omics and cell painting are transforming early prediction in pre-clinical research. How can we understand what the consequences of that are?”

Drugs 73
article thumbnail

What Makes a Mature Science

Codon

The alchemy of van Helmont’s day was not a mature science. At some point between the 17th and 18th centuries, the study of matter and substance went from being an immature science, a bunch of people hanging around and wearing funny hats, to a mature one, a bunch of scientists hanging around and wearing funny hats.

Science 79
article thumbnail

MIA: Noor Pratap Singh, RNA-Seq data using a tree-based framework; Primer: Rob Patro

Broad Institute

To address these challenges, we introduce a data-driven tree-based framework that incorporates uncertainty into RNA-seq data analysis. In the first part of the talk, I will discuss existing approaches for handling uncertainty and their limitations in RNA-seq data analysis before introducing TreeTerminus.

RNA 52